MDS Virtual Congress 2020 Archives - Page 74 of 149

Increased neurofilament light chain plasma levels as a biological marker of mild cognitive impairment in Parkinson’s disease

J. Pagonabarraga, R. Perez-Gonzalez, H. Bejr-Kasem, J. Marin-Lahoz, A. Horta-Barba, I. Aracil-Bolaños, F. Sampedro, S. Martinez-Horta, J. Perez-Perez, B. Pascual-Sedano, J. Kulisevsky (Barcelona, Spain)
Increased risk of Parkinson’s disease in patients with schizophrenia spectrum disorders

T. Kuusimäki, H. Al-Abdulrasul, S. Kurki, J. Hietala, S. Hartikainen, M. Koponen, A. Tolppanen, V. Kaasinen (Turku, Finland)
Increased Syllable Duration as a Marker for Dysarthria in Essential Tremor Patients with Deep Brain Stimulation

H. Jergas, J.N Petry-Schmelzer, T. Thies, J. Steffen, H. Dafsari, D. Muecke, V. Visser-Vandewalle, T. Dembek, M. Barbe (Cologne, Germany)
Indication and long-term outcome of device-aided therapies in advanced Parkinson’s disease

M. Shiraishi, F. Maki, M. Kato, Y. Morosawa, I. Takumi, K. Isahaya, N. Sasaki, Y. Hasegawa (Kawasaki, Japan)
Inertial sensor-based kinematics in the differential diagnosis of Parkinson’s disease and atypical parkinsonisms

M. Mendonça, P. Ferreira, R. Barbosa, B. Meira, J. da Silva, R. Costa, R. Matias (Lisboa, Portugal)
Inertial-sensor based full-body kinematics reveals an unstable gait with increased variability in patients with evidence of dopaminergic denervation with 123I-FP-CIT SPECT

M. Mendonça, J. Silva, F. Oliveira, A. Oliveira-Maia, J. Ferreira, D. Costa, R. Costa, R. Matias (Lisboa, Portugal)
Influence of emotion-affective apathy in theory of mind in Parkinson’s disease patients

O. Lucas-Jiménez, N. Ojeda, J. Peña, I. Gabilondo, A. Murueta-Goyena, J.C Gómez-Esteban, R. del Pino, M. Acera, N. Ibarretxe-Bilbao (Bilbao, Spain)
Influencing factors when living with Parkinson’s disease: beyond the disease symptomatology

L. Ambrosio, P. Martinez-Martin, C. Rodriguez-Blazquez, M.C Portillo (Pamplona, Spain)
Information processing components in Parkinson’s disease with and without impulse control disorders: identification of diagnostic and predisposition markers

S.. Cantarero Duque, J.P Romero (Madrid, Spain)
Inhaled levodopa (LD) as a treatment for Parkinson’s disease (PD) patients in an emergency setting

S. Miri, S. Nakano, A. Carwin, M. Anjum, Y. Torres-Yaghi, F. Amjad, F. Pagan (Washington, DC, USA)